Perritt Capital Management’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$967K Buy
130,100
+5,000
+4% +$34.3K 1.62% 19
2025
Q3
$849K Buy
125,100
+20,200
+19% +$137K 0.4% 50
2025
Q2
$725K Sell
104,900
-600
-0.6% -$4.07K 0.37% 49
2025
Q1
$768K Buy
105,500
+20,500
+24% +$161K 0.42% 39
2024
Q4
$682K Hold
85,000
0.35% 56
2024
Q3
$623K Buy
85,000
+6,000
+8% +$42.9K 0.32% 69
2024
Q2
$517K Hold
79,000
0.28% 84
2024
Q1
$745K Hold
79,000
0.4% 52
2023
Q4
$620K Hold
79,000
0.35% 63
2023
Q3
$532K Buy
79,000
+2,930
+4% +$24K 0.31% 86
2023
Q2
$744K Hold
76,070
0.41% 56
2023
Q1
$735K Hold
76,070
0.41% 57
2022
Q4
$575K Buy
+76,070
New +$515K 0.33% 77

Other funds holding VMD

Perritt Capital Management's VMD Position: Q4 2025 in Review

Perritt Capital Management increased its Viemed Healthcare (VMD) stake by 4% in Q4 2025, buying an estimated $34.3K and bringing the position to 130,100 shares worth $967K. The position accounts for 1.62% of the portfolio, ranked #19.

Perritt Capital Management first reported a position in VMD in Q4 2022 and has held it in 13 quarters since. 132 funds tracked by Wall St. Rank hold VMD as of Q4 2025.

  • Perritt Capital Management held 130,100 shares of Viemed Healthcare worth $967K as of Q4 2025.
  • Perritt Capital Management bought 5,000 Viemed Healthcare shares in Q4 2025, an estimated $34.3K.
  • Viemed Healthcare made up 1.62% of Perritt Capital Management's portfolio in Q4 2025, its #19 holding.
  • Perritt Capital Management first reported a position in Viemed Healthcare in Q4 2022 and has held it in 13 quarters since.
  • 132 funds tracked by Wall St. Rank held Viemed Healthcare as of Q4 2025.

Based on Perritt Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.